Vertex Pharmaceuticals Inc (VRTX) — Defensive Interval Ratio
Vertex Pharmaceuticals Inc (VRTX) has a Defensive Interval Ratio of 353 days as of March 2026. Defensive assets of $3.75 Billion (cash $-, short-term investments $1.75 Billion, receivables $2.00 Billion) cover 353 days of daily cash needs of $10.63 Million/day. Check how tangible is Vertex Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Vertex Pharmaceuticals Inc Defensive Interval Ratio (1999–2025)
This chart shows how Vertex Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 27 annual periods from 1999 to 2025. As of March 2026, the ratio stands at 353 days, meaning defensive assets of $3.75 Billion can fund 353 days of operations without new revenue. Also explore Vertex Pharmaceuticals Inc (VRTX) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Vertex Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Defensive Interval Ratio for Vertex Pharmaceuticals Inc from 1999 to 2025, covering 27 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Vertex Pharmaceuticals Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 338 days | $3.58 Billion | $10.58 Million/day | $- | $1.52 Billion | ▲ +15 days |
| 2024 | 323 days | $3.16 Billion | $9.77 Million/day | $- | $1.55 Billion | ▲ +75 days |
| 2023 | 248 days | $2.41 Billion | $9.72 Million/day | $- | $849.20 Million | ▲ +20 days |
| 2022 | 229 days | $1.72 Billion | $7.51 Million/day | $- | $274.50 Million | ▼ -90 days |
| 2021 | 318 days | $1.87 Billion | $5.87 Million/day | $- | $729.90 Million | ▲ +16 days |
| 2020 | 303 days | $1.56 Billion | $5.14 Million/day | $- | $670.70 Million | ▼ -62 days |
| 2019 | 364 days | $1.33 Billion | $3.66 Million/day | $- | $698.97 Million | ▼ -109 days |
| 2018 | 473 days | $927.80 Million | $1.96 Million/day | $- | $518.11 Million | ▲ +155 days |
| 2017 | 319 days | $704.60 Million | $2.21 Million/day | $- | $423.25 Million | ▼ -20409 days |
| 2016 | 20728 days | $451.69 Million | $21.79K/day | $- | $250.61 Million | ▲ +20364 days |
| 2015 | 364 days | $505.33 Million | $1.39 Million/day | $- | $327.69 Million | ▼ -480 days |
| 2014 | 844 days | $851.90 Million | $1.01 Million/day | $- | $761.85 Million | ▼ -56 days |
| 2013 | 900 days | $981.29 Million | $1.09 Million/day | $- | $895.78 Million | ▲ +78 days |
| 2012 | 823 days | $975.06 Million | $1.19 Million/day | $- | $831.81 Million | ▲ +528 days |
| 2011 | 294 days | $676.74 Million | $2.30 Million/day | $- | $493.60 Million | ▼ -321 days |
| 2010 | 616 days | $800.74 Million | $1.30 Million/day | $- | $788.21 Million | ▼ -471 days |
| 2009 | 1086 days | $847.86 Million | $780.50K/day | $- | $838.25 Million | ▲ +300 days |
| 2008 | 786 days | $466.48 Million | $593.33K/day | $- | $442.99 Million | ▲ +536 days |
| 2007 | 250 days | $136.53 Million | $545.97K/day | $- | $105.21 Million | ▼ -556 days |
| 2006 | 806 days | $554.38 Million | $687.71K/day | $- | $491.45 Million | ▼ -300 days |
| 2005 | 1106 days | $303.71 Million | $274.64K/day | $- | $283.11 Million | ▲ +277 days |
| 2004 | 829 days | $349.20 Million | $421.22K/day | $- | $337.31 Million | ▼ -463 days |
| 2003 | 1292 days | $492.33 Million | $381.01K/day | $- | $485.00 Million | ▼ -1760 days |
| 2002 | 3052 days | $540.09 Million | $176.98K/day | $- | $526.89 Million | ▲ +762 days |
| 2001 | 2289 days | $574.26 Million | $250.83K/day | $- | $554.00 Million | ▲ +1765 days |
| 2000 | 525 days | $100.42 Million | $191.39K/day | $- | $66.51 Million | ▲ +407 days |
| 1999 | 117 days | $5.96 Million | $50.73K/day | $- | $- | — |